The development of the new crown prevention medicine has made progress, and the domestic team submits preclinical data

The reporter learned from the Chongqing Medical University recently that Professor Huang Ailong, President of Chongqing Medical University and a team led by Professor Jin Aishun's team led by the new crown Omir Rong mutant strain, has completed all pre -clinical research, related papersRecently published in the journal "Signal Director and Treatment", the relevant data has been submitted to the New Drug Review Center of the State Drug Administration, and further clinical trials are planned in the future.

Responsible editor: Shi Jian | Audit: Li Zhen | Director: Wan Junwei

- END -